Poland is growing faster then other EU countries and there is good base to build a winning life science cluster. ±€5 bil in pharma/y, ±€1bil in medical devices/y, 8000 local life science companies, about 1000 Hospitals and 20k clinics or 6H beds /000 (2x than the USA and 1.5x then CH) is a good start. Bioengineering MSc degrees are issued in english in more than one University and this adds more skills and specialized staff in the market; however all this needs a boost as there is yet not enough concentration of interconnected businesses, free contractors, associated institutions and startup wins to evidence a clear self regeneration. Some of Poland new round of grants (±€5 bil /year in development) could help if intentionally directed to this sector and partially adapted to the special requirements life science early stage projects need to achieve commercialization.
The first “exported” life science project to Poland is about a small non-invasive ear-VNS treatment of cognitiver impairement degeneration / Alzheimer’s Disease @ Home. Animal studies are conducted in Lodz. .. http://pulsinnowacji.pb.pl/4638514,20557,ojciec-start-upow-inwestuje-w-polsce
opened new PBV Lynx offices in: Natolin 15, 92-703 Łódź, Poland
Formed LYNX PBV: a Consulting Company exclusively serving as Director of Investments at BSD GROWTH to be set up as a self managed fund based in Gibraltar. LYNX PBV role will be to recommend investments of the BSD GROWTH Fund and then escort the targeted companies from as early as a post proof of concept (POC) stage into an exit; its services also include improving business registration for entrepreneurs, streamlining the process for transferring property, reducing the time required to enforce contracts, and minimizing insolvency. http://lynxpbv.com/
Yigal Erlich, Adam Broncel and David Vita @ Bioforum in Lodz 2016